Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The so-called "SSU72 like 6" (SSU72L6), also referred to as "SSU72 pseudogene 8" and other similar names, appears to represent a **pseudogene** or non-functional homolog related to the genuine *Ssu72* phosphatase, which is an enzyme crucial for regulating transcription by dephosphorylating the C-terminal domain (CTD) of RNA polymerase II[2][3][5]. The well-characterized Ssu72 is an essential phosphatase involved in key steps of the eukaryotic transcription cycle, mRNA processing, and possibly phosphate homeostasis; it participates directly in dephosphorylating CTD serine-5 and sometimes serine-7 residues[1][2][3][5]. However, **no evidence in current biomedical or pharmacological literature supports SSU72L6 as an active enzyme, receptor, or therapeutic target**; rather, its gene product is most likely an unprocessed pseudogene without any demonstrated function, biological activity, or disease relevance. **Key clarification:** The biologically active phosphatase is named "RNA polymerase II subunit A C-terminal domain phosphatase Ssu72" (abbreviated as SSU72), not SSU72L6. Based on current scientific knowledge, SSU72L6 is *not* a therapeutic target, and no interacting drugs, roles in human diseases, or clinical biomarkers are established for it. If your focus is the functionally validated transcriptional phosphatase, refer to "RNA polymerase II subunit A C-terminal domain phosphatase Ssu72" (SSU72); SSU72L6 designates a likely non-coding, non-functional pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA polymerase II subunit A C-terminal domain phosphatase Ssu72-like protein 6 (SSU72L6).